The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods

Documenti analoghi

• Patient representatives' contributions to the benefit‐risk assessment tasks of the European Medicines Agency scientific committees
  di: Bernabe, Rosemarie D L C, et al.
  Pubblicazione: (2014)
• The fiduciary obligation of the physician-researcher in phase IV trials
  di: Bernabe, Rosemarie DLC, et al.
  Pubblicazione: (2014)
• What do international ethics guidelines say in terms of the scope of medical research ethics?
  di: Bernabe, Rosemarie D. L. C., et al.
  Pubblicazione: (2016)
• Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?
  di: Bernabe, Rosemarie D. L. C., et al.
  Pubblicazione: (2020)
• Phase IV non-inferiority trials and additional claims of benefit
  di: Bernabe, Rosemarie DLC, et al.
  Pubblicazione: (2013)